Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

Novo Nordisk faces slowing demand, rising competition, and CEO transition. Learn about challenges impacting its growth and ...

We recently published 10 Stocks That Jim Cramer Talked About. CVS Health Corporation (NYSE:CVS) is one of the stocks Jim ...

In their zeal to "Make America Healthy Again," top Trump administration officials depict patients and the doctors who treat ...

We recently published 10 Stocks That Jim Cramer Talked About. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim ...

Novo Nordisk stock plunges 22% after slashing 2025 sales and profit outlooks, citing weak GLP-1 drugs' uptake and rising ...

Incannex's IHL-42X showed significant efficacy in Phase 2 sleep apnea trial, with strong AHI reduction, improved sleep, and ...

Drugmaker struggled to adapt to very high demand and a market where celebrities are more influential than doctors ...

ASX companies such as LTR Pharma are finding smarter ways to stretch the value of existing assets and launch into broader ...

Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session ...

The new CVS contract for Wegovy and stepped-up direct-to-patient outreach offer concrete levers to boost U.S. volume as early as Q3, helping to stabilize demand in the face of compounding pharmacy ...

It seems counterintuitive, if not implausible, that a company which has revolutionised Western health and promises to ...